Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Health Commission hears how Bay Area is joining major vaccine trials and plans outreach to reach communities of color
Summary
Dr. Susan Buchbinder briefed the commission on COVID-19 vaccine trials, including AstraZeneca's CoVPN trial, emphasizing phase‑3 testing needs, safety review after a U.K. pause, and outreach to ensure diverse enrollment in San Francisco.
Dr. Susan Buchbinder, speaking for the local CoVPN site network, told the Health Commission the department and partners are preparing to run and recruit for large phase‑3 vaccine trials and are prioritizing community engagement to enroll populations most affected by COVID-19.
"So what is it that we're hoping that a COVID vaccine could do?" Buchbinder asked rhetorically during her Sept. 15 presentation. She described objectives ranging from reduced disease severity to lowered transmission and noted most vaccine candidates target the virus's spike protein.
Buchbinder outlined how vaccine testing proceeds through preclinical and phased human trials and said acceleration efforts like Operation Warp Speed…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
